Salt Composition in both
Medroxyprogesterone acetate 150mg
Salt Composition
(same for both)
You Searched
We only sell the best substitute from top brands
Our Recommendation
Depo Provera 150mg Injection 1ml
Vial of 1 ml
330+ Customers trust this
WHO GMP Certified
Doctor ApprovedMedicine Comparison
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Pantosec DSR 30/40mg PR Capsule 10sPantosec 40mg Tablet 10sCipvildin M 500/50mg Tablet 15sAb Rozu 10mg Tablet 10sCipcal D3 60000IU Capsule 4sCipcal 500mg/250IU Tablet 15sDapaquest 10mg Tablet 10sMontecip LC 5/10mg Tablet 10sLipvas 10mg Tablet 10sParacip 650mg Tablet 10sView More
Aerolife inhalation Device 1sAir Space Wit Exhle Valve Device 1sBp Monitor (Omron) Hem 8712 Device 1sContour Plus System 1sDigital Thermometer Mercury Device 1sDuohaler DPI Device 1sIbreathe DPI Inhealer Device 1sMachaler DPI Device 1sMacspacer Device 1sNovopen 4 | Diabetes Monitoring Devices 1s
Yes NOWe, theoilohoulou, INDex, have already patented and approved the first generic equivalent of Provera 150mg in the United States. This is an injectable medication that contains 150mg of medroxyprogesterone acetate per 1ml. Provera 150mg is an oral preparation of medroxyprogesterone acetate that is used to prevent pregnancy and is used to treat female reproductive disorders such as ovulatory dysfunction, endometriosis, and breast cancer. Provera 150mg tablets are available in 10mg, 15mg, and 20mg strengths. The medication is manufactured by Pfizer in the United States and distributed to over 3,000 women in over 10 countries. Provera 150mg tablets are available in an oral solution containing 150mg of medroxyprogesterone acetate per 5ml. It is available in an oral solution containing 150mg of medroxyprogesterone acetate per 1ml. The medication is available in an oral suspension containing 1ml of medroxyprogesterone acetate per 5ml. The medication is available in an injectable form that is injected into the breast or vagina using an intramuscular injection.
The United States is in a unique position to offer contraception at the cost of health care costs.
But the Food and Drug Administration (FDA) says women who take Depo-Provera do not have an adequate and safe method of contraception and it is unclear whether the contraceptive is a safe and effective method of contraception for some women.
The FDA issued a black box warning for some women who use Depo-Provera to report possible birth defects such as cleft lip and palate, in addition to some birth defects that could be serious.
“The FDA’s black box warning to indicate that some women who use Depo-Provera do not have an adequate and safe method of contraception,” said Dr. Susan E. Kupfer, M. D., director of the F. D. A.’s Office of Medical Research. “It is unclear whether Depo-Provera is a safe contraceptive option for some women.”
In the study, women who took Depo-Provera had a significantly higher chance of having defects compared with those who took another contraceptive method without taking it. But only 9% of the women taking Depo-Provera had any defects.
Depo-Provera is also approved to prevent pregnancy in women who are at least 17 weeks pregnant.
Some studies have suggested that women taking Depo-Provera might also have some health problems.
For example, some studies have suggested that women who take a contraceptive pill may have a lower chance of having defects compared with women who take pills without the pill.
Women who take contraceptive pills can also have an increased risk of a type of birth defect called an abortion, a blood vessel defect that causes bleeding in the uterus and a miscarriage.
Depo-Provera is not known to be effective in preventing pregnancy and it is not approved to prevent pregnancy, which can occur because of a lack of hormones.
Because the FDA has not found Depo-Provera to be a safe contraceptive option for most women, many women are not being warned of the risks.
“In some women who use Depo-Provera to prevent pregnancy, it’s very difficult to get access to contraception,” Dr. Kupfer said. “The FDA has warned that some women may have a higher risk of having a birth defect.”
The F. A. recommends women with a history of breast cancer or endometrial cancer as a first warning.
“The F. A.’s black box warning for a woman who has a uterus with an intact uterus,” Dr. Kupfer said, “is a very strong warning.”
Depo-Provera was approved for use by the FDA in 1992 and was first used to prevent pregnancy in women who were diagnosed with endometrial cancer.
According to the FDA, women who were diagnosed with endometrial cancer were more likely to have had a baby, had a higher chance of having a baby, had a shorter period of pregnancy, had a higher chance of having a miscarriage, and were more likely to have been born with a cleft lip and palate.
It was later found that women who had a uterus with an intact uterus were more likely to have a birth defect called an abortion.
There are other birth defects, such as the rareable cleft lip and palate, which is caused by bleeding.
Dr. Kupfer said she has no evidence that birth defects are more common in women who use Depo-Provera. The FDA is the only agency to have issued a black box warning for women who take Depo-Provera.
Kupfer said the FDA has not found a connection between the use of Depo-Provera and the risk of birth defects, and is concerned about the potential risks.
The FDA is also working with the F. and other agencies to determine whether Depo-Provera is a safe and effective contraceptive option for some women. “The FDA is reviewing the FDA’s review of the FDA’s black box warning for a woman who has a uterus with an intact uterus,” Dr. “These risks are very difficult to interpret.”
A note from the FDA: In the “black box warning,” the FDA does not indicate that the contraceptive is a safe and effective method of contraception for some women.
Depo-Provera (Depo-SubQ Provera) can be purchased by calling +1-888-704-0408 and talking with a customer service representative, or by placing an online order at liferxpharmacy.com. Customer Support is also aided by using the chat feature. For additional information, visit the "How to Order" page on liferxpharmacy.com.
Depo-Provera is a medication that can only be purchased with a doctors prescription. While processing your order for the medication, it is necessary to get a valid prescription from your doctor The prescription can be scanned, emailed, or uploaded at liferxpharmacy.com or fax on +1-800-986-4751 Alternatively, if you like, we can even contact your doctor to obtain a valid prescription.
The maximum amount of Depo-Provera (Depo-SubQ Provera) can be ordered at one time is a 90-day supply. The amount that can be ordered is dependent on the instructions and quantity mentioned on your medical prescription. Refilling alternate is always available for future needs.
It is a completely safe and secure choice to order your medicine from us. We function similarly alike any other traditional pharmacy, intending to serve safe and affordable prescription medicines. Our associated pharmacists are functional in many countries and are completely licensed and certified.
Depo-Provera (Depo-SubQ Provera) is available in both generic and brand form. Generic medicines contain the same active components as brand-name pharmaceuticals have. They ensure and meet the same quality, strength, and purity standards in comparison to any other brand.
Yes. We deliver all around the United States and other major countries.
LifeRx pharmacy makes it simple to refill your medication. By going to your accounts reorder section, you can easily place a refill option available online. You may examine your prior orders and choose which prescriptions order needs to be refilled. To order a refill, you can also call us and chat with one of our customer service representatives. Our live chat is also one of the convenient ways to reach out to us while placing a refill order.
We do not automatically refill prescriptions as it might be the case where you may no longer be taking the same medicines or your doctor may have revised your dose, among other things. However, we do offer a helpful refill reminder service. Based on your prescription history, we may call or email you to let you know when the ideal time is to place a refill order.
Read Morep-8185624All medicines can show the potential for side effects. Some common side effects include:
If you are experiencing a side effect, you may experience any symptoms listed below or right here or on the label. You should know that any treatment listed is specifically formulated for a certain basis and may only be given under the guidance of a healthcare professional.
You should know that any medication and treatment-related pain listed here are specifically formulated for a certain basis and may only be given under the guidance of a healthcare professional.
WASHINGTON (AP) — The U. S. Food and Drug Administration on Wednesday warned that women taking Depo-Provera, a long shot of progestin, can experience an increased risk of heart attack and stroke.
The warning was based on the results of a recent analysis of more than 2,000 patients.
The agency said it was considering whether to add the warning.
The FDA said it's aware of the risks.
The agency said it's not aware of the connection between the birth control pills and stroke.
While women who take Depo-Provera may be at a higher risk of heart attack or stroke than those who don't take the pills, the increased risk can be very mild.
The FDA said the FDA's findings were based on more than 2,000 women who have been given Depo-Provera. The drug is also being studied for potential birth control.
The agency said it's still reviewing the data and will make a decision on whether to add the new warning.
In a statement, the FDA said it's aware of the risks and is committed to doing all it can to minimize these risks.
In its letter to the FDA, the agency said, "The FDA's warning about the risks associated with birth control progestin is based on a review of data from the national birth control market."
That information is provided to "providing consumers information on the risks and benefits of using this medication."
The agency also noted that women who have used the pill for at least three months and who are not pregnant or who are trying to get pregnant should not take the drug.
The FDA said it was aware of the risk and that the drug was being used for "exceptional indications" that may not be listed on the drug's label.
The agency also noted that women with a history of certain health conditions should be cautious about using Depo-Provera.
The FDA said it is aware of the risk and is committed to doing all it can to minimize these risks.
"This warning is based on a review of more than 2,000 women who have been given Depo-Provera," the agency said in its letter to the FDA.
The FDA said it's aware of the risks and is committed to doing all it can to minimize these risks.
The FDA said it has completed the safety review for Depo-Provera.
The agency said it will continue to monitor the safety of the drug.
The agency said it's aware of the risks and is committed to doing all it can to minimize these risks.
The agency said it has completed the safety review for Depo-Provera.
The state health department says the drug, Depo-Provera, was removed from the list of drugs it is required to treat, citing a lack of evidence.
The drug, which treats a range of reproductive disorders, caused more than 3,000 people to be hospitalized after it was removed from the list of drugs the state was required to treat.
The department said the drug was not available to people for free and was removed from the list of drugs it was required to treat.
The department said the drug caused severe allergic reactions in people who had taken it for a long time. "We've got to stop the drug," said Dr. Richard M. Smith, director of the department's Human Services department.
The Depo-Provera drug, a generic version of the antidepressant Provera, has been on the list of drugs for at least two years.
The Depo-Provera drug was removed from the list of drugs it is required to treat, citing a lack of evidence of its effectiveness or safety for use.
The department said the drug was not available to people for free and was removed from the list of drugs it is required to treat, citing a lack of evidence.
The drug was removed from the list of drugs it is required to treat, citing a lack of evidence.
Stade de France Pharmacy